论文部分内容阅读
目的:分析病毒性肝病生化检验结果和临床价值。方法:以我院收治的75例病毒性肝病患者作为试验组,同期体检健康人员40例作为对照组。抽取血液样本检验各项肝功能指标,比较试验组和对照组的阳性检出率,以及不同肝病患者的肝功能指标水平。结果:试验组患者ALT、AST、CHE、TBIL阳性率为82.7%、84.0%、86.7%、90.7%,均高于对照组的12.5%、22.5%、7.5%、27.5%;急性/慢性肝炎患者PA水平增高明显,慢性肝炎、肝癌患者ADA水平增高明显,肝癌患者LAP水平增高明显。P<0.05,差异有统计学意义。结论:病毒性肝病患者的肝功能指标明显提高,且和病情具有一定关联,可以作为临床诊断、预后评估的参考依据。
Objective: To analyze the biochemical test results and clinical value of viral liver disease. Methods: Seventy-five patients with viral liver disease treated in our hospital were selected as the experimental group and 40 healthy subjects were selected as the control group. Blood samples were taken to test various liver function indexes, the positive detection rate of the test group and the control group were compared, and the liver function indexes of patients with different liver diseases were compared. Results: The positive rates of ALT, AST, CHE and TBIL in the test group were 82.7%, 84.0%, 86.7% and 90.7%, respectively, which were all higher than those in the control group (12.5%, 22.5%, 7.5% and 27.5% PA levels increased significantly, chronic hepatitis, liver cancer patients ADA increased significantly, LAP levels increased significantly in patients with liver cancer. P <0.05, the difference was statistically significant. Conclusion: The indexes of liver function in patients with viral liver disease are significantly improved, and have certain correlation with the condition, which can be used as reference for clinical diagnosis and prognosis evaluation.